🚀 VC round data is live in beta, check it out!
Medicofarma Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medicofarma Biotech and similar public comparables like Magle Chemoswed Holding, Bolt Biotherapeutics, Futura Medical, Vivesto and more.
Medicofarma Biotech Overview
About Medicofarma Biotech
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.
Founded
2001
HQ
Employees
2
Website
Sectors
Financials (FY)
EV
$9M
Medicofarma Biotech Financials
Medicofarma Biotech reported last fiscal year revenue of $33K and negative EBITDA of ($60K).
In the same fiscal year, Medicofarma Biotech generated ($20K) in gross profit, ($60K) in EBITDA losses, and had net loss of ($621K).
Medicofarma Biotech P&L
In the most recent fiscal year, Medicofarma Biotech reported revenue of $33K and EBITDA of ($60K).
Medicofarma Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $33K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($20K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (61%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($60K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (179%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (1339%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($621K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (1860%) | XXX | XXX | XXX |
| Net Debt | — | — | $0K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medicofarma Biotech Stock Performance
Medicofarma Biotech has current market cap of $9M, and enterprise value of $9M.
Market Cap Evolution
Medicofarma Biotech's stock price is $0.14.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $9M | 0.1% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedicofarma Biotech Valuation Multiples
Medicofarma Biotech trades at 276.7x EV/Revenue multiple, and (154.6x) EV/EBITDA.
Medicofarma Biotech Financial Valuation Multiples
As of April 19, 2026, Medicofarma Biotech has market cap of $9M and EV of $9M.
Equity research analysts estimate Medicofarma Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medicofarma Biotech has a P/E ratio of (14.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 276.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (154.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (20.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (450.8x) | XXX | XXX | XXX |
| P/E | — | XXX | (14.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (33.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medicofarma Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medicofarma Biotech Margins & Growth Rates
Medicofarma Biotech's revenue in the last fiscal year declined by (90%).
Medicofarma Biotech's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Medicofarma Biotech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (90%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (179%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (60%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1277% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medicofarma Biotech Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medicofarma Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Magle Chemoswed Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Bolt Biotherapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Futura Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivesto | XXX | XXX | XXX | XXX | XXX | XXX |
| Chosa Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicofarma Biotech M&A Activity
Medicofarma Biotech acquired XXX companies to date.
Last acquisition by Medicofarma Biotech was on XXXXXXXX, XXXXX. Medicofarma Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medicofarma Biotech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedicofarma Biotech Investment Activity
Medicofarma Biotech invested in XXX companies to date.
Medicofarma Biotech made its latest investment on XXXXXXXX, XXXXX. Medicofarma Biotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medicofarma Biotech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medicofarma Biotech
| When was Medicofarma Biotech founded? | Medicofarma Biotech was founded in 2001. |
| Where is Medicofarma Biotech headquartered? | Medicofarma Biotech is headquartered in Poland. |
| How many employees does Medicofarma Biotech have? | As of today, Medicofarma Biotech has over 2 employees. |
| Is Medicofarma Biotech publicly listed? | Yes, Medicofarma Biotech is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Medicofarma Biotech? | Medicofarma Biotech trades under MDB ticker. |
| When did Medicofarma Biotech go public? | Medicofarma Biotech went public in 2008. |
| Who are competitors of Medicofarma Biotech? | Medicofarma Biotech main competitors are Magle Chemoswed Holding, Bolt Biotherapeutics, Futura Medical, Vivesto. |
| What is the current market cap of Medicofarma Biotech? | Medicofarma Biotech's current market cap is $9M. |
| What is the current revenue of Medicofarma Biotech? | Medicofarma Biotech's last fiscal year revenue is $33K. |
| What is the current EV/Revenue multiple of Medicofarma Biotech? | Current revenue multiple of Medicofarma Biotech is 276.7x. |
| Is Medicofarma Biotech profitable? | No, Medicofarma Biotech is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.